Neurocognitive Disorders: Clinical Trials

134 trials for Neurocognitive Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

134 unknown. 134 Phase 2, 28 Phase 1, 19 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2134Unknown 134
Phase 128Unknown 28
Phase 319Unknown 19

Follow Neurocognitive Disorders: new trials by email Literature Review of Neurocognitive Disorders trials Research Report on Neurocognitive Disorders

Trials (filtered) newest first · largest first

All 134 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cannabidiol's Role in Dementia Management
Cannabidiol Oil - Dementia, Vascular, Dementia, Mixed
Phase 2 / Phase 3UnknownHospital Pengajar Universiti Putra Malaysia4862024-09-012024-07-23
Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries
Ketamine, Dexmedetomidine - Emergence Delirium
Phase 1 / Phase 2UnknownCairo University462024-08-102024-08-20
Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's Disease
10g Astragalus, Routine treatment, 20g Astragalus - Alzheimer's Disease
Phase 2UnknownFujian Medical University Union Hospital662024-05-012024-07-03
Effect of Pentoxifylline on Cognitive Impairment After Ischemic Stroke
Pentoxifylline - Cognitive Impairment
Phase 1 / Phase 2UnknownThe First Hospital of Hebei Medical University2002024-04-102024-04-03
Remimazolam for Emergence Delirium Prevention in Patients Undergoing Rhinoseptoplasty, FESS or Septoplasty
Remimazolam 20 MG Injection [Byfavo], NaCl 0.9% - Remimazolam, Emergence Delirium
Phase 2UnknownUniversity Hospital of Split802024-03-062024-05-03
Efficacy, Safety and Response Predictors of Adjuvant Astragalus for Cognition in Orthostatic Hypotension
Routine treatment, add-on low dose Astragalus, add-on high dose Astragalus - Orthostatic Hypotension, Alzheimer Disease
Phase 2UnknownFujian Medical University Union Hospital662024-02-202024-01-05
Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care
Dexmedetomidine Hydrochloride - Hyperactive Delirium, Delirium of Mixed Origin
Phase 1 / Phase 2UnknownBruyère Health Research Institute.502024-01-302025-04-15
Safety and Efficacy of AR1005 in Patients with Lewy Body Disease
AR1005, Placebo, Rivastigmine 3 mg - Lewy Body Dementia
Phase 2UnknownYonsei University602024-01-012024-10-02
A Comprehensive Fall Prevention System for Memory Care: Final Feasibility and Randomized Controlled Study
SafelyYou, Control - Dementia
Phase 2UnknownSafelyYou3002023-10-312022-05-09
Randomized Clinical Trial of Donepezil for the Treatment of Mild Cognitive Impairment in Parkinson's Disease
Donepezil Hydrochloride, Placebo - Parkinson Disease, Mild Cognitive Impairment
Phase 2UnknownFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1202023-10-012023-09-28
Dexmedetomidine Versus Ketamine Versus Magnesium Sulfate for the Prevention of Emergence Agitation Following Sevoflurane Induced Anesthesia in Cardiac Catheterization in Pediatrics
Dexmedetomidine, Ketamine, Magnesium - Anesthesia Emergence Delirium
Phase 1 / Phase 2UnknownCairo University1002023-09-202023-10-11
tDCS in the Management of Post-COVID Disorders
Transcranial Direct Current Stimulation (tDCS), Motor Training, Cognitive Training - Long COVID
Phase 2UnknownUniversidade Federal de Pernambuco482023-08-252024-04-24
Effect of Menopause Hormone Therapy In Postmenopausal Women With CSVD And MCI
Estradiol Gel, Estradiol Placebo Gel, Progesterone Soft Capsule - Cerebral Small Vessel Diseases, Postmenopausal Symptoms
Phase 2UnknownBeijing Tiantan Hospital3282023-08-182023-08-08
Electroacupuncture for Chemotherapy-Related Cognitive Impairment
Electroacupuncture, Sham acupuncture - Chemotherapy-Related Cognitive Impairment
Phase 2UnknownBeijing University of Chinese Medicine1002023-08-012023-07-14
Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease
APH-1105, Placebo - Dementia, Alzheimer Disease 1
Phase 2UnknownAphios602023-06-012021-07-27
Tdap and Biomarkers of Alzheimer's Disease
tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine - Alzheimer Disease, Late Onset
Phase 1 / Phase 2UnknownMindful Diagnostics and Therapeutics, LLC502023-05-012022-08-25
Protecting Alzheimer Caregivers Using Technology Through Staying Sharp
Staying Sharp intervention - Mild Cognitive Impairment, Dementia Alzheimers
Phase 1 / Phase 2UnknownOregon Health and Science University1382023-04-302023-02-09
Systemic and Central Inflammation in AD
11C-ER176 - Alzheimer Disease
Phase 2UnknownThe Methodist Hospital Research Institute402023-03-172024-04-25
Amantadine for Neuroenhancement in Acute Patients Study
Amantadine - Disorder of Consciousness
Phase 2UnknownUniversity Hospital Tuebingen502023-03-012024-02-01
Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease
AstroStem, Placebo - Alzheimer Disease
Phase 2UnknownNature Cell Co. Ltd.1002023-02-012022-09-28

Showing 20 of 134. Sign in to see all of them.

Narrower conditions

Alzheimer Disease (61)  ·  Cognitive Dysfunction (43)  ·  Dementia (15)  ·  Dementia, Vascular (11)  ·  Parkinson Disease (6)  ·  Cognition Disorders (5)  ·  Consciousness Disorders (5)  ·  Delirium (5)  ·  Emergence Delirium (5)  ·  Frontotemporal Dementia (5)  ·  Memory Disorders (4)  ·  Brain Injuries, Traumatic (3)  ·  Huntington Disease (3)  ·  Lewy Body Disease (3)

Broader conditions

Mental Disorders (133)  ·  Nervous System Diseases (108)  ·  Brain Diseases (93)  ·  Central Nervous System Diseases (93)  ·  Neurodegenerative Diseases (75)  ·  Dementia (71)  ·  Tauopathies (62)  ·  Cognition Disorders (46)  ·  Pathological Conditions, Signs and Symptoms (36)  ·  Signs and Symptoms (26)  ·  Neurologic Manifestations (25)  ·  Neurobehavioral Manifestations (21)  ·  Cardiovascular Diseases (17)  ·  Pathologic Processes (17)

Interventions

Donepezil (8)  ·  Dexmedetomidine (5)  ·  Sodium Chloride (4)  ·  Injections (3)  ·  Ketamine (3)  ·  Acupuncture Therapy (2)  ·  Amantadine (2)  ·  Aspirin (2)  ·  Electroacupuncture (2)  ·  Levetiracetam (2)  ·  Melatonin (2)  ·  Memantine (2)  ·  Rivastigmine (2)  ·  Saline Solution (2)  ·  Transcranial Direct Current Stimulation (2)

Sponsors

Chang Gung Memorial Hospital (8)  ·  Assiut University (2)  ·  Beijing Tiantan Hospital (2)  ·  Cairo University (2)  ·  Dongzhimen Hospital, Beijing (2)  ·  Federal University of Paraíba (2)  ·  Fujian Medical University Union Hospital (2)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2)  ·  Maastricht University Medical Center (2)  ·  Oregon Health and Science University (2)  ·  Peking Union Medical College Hospital (2)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (2)  ·  Tel-Aviv Sourasky Medical Center (2)  ·  The Methodist Hospital Research Institute (2)  ·  University College, London (2)

Countries

United States (31)  ·  China (23)  ·  Brazil (7)  ·  Egypt (7)  ·  Taiwan (7)  ·  Canada (5)  ·  Netherlands (5)  ·  South Korea (5)  ·  France (4)  ·  Israel (4)  ·  United Kingdom (4)  ·  Australia (3)  ·  Belgium (3)  ·  Italy (3)  ·  Singapore (3)

Top investigators

Adriana Baltar, PhD (1)  ·  Alexander Kaplan (1)  ·  Alexandre Chan, Pharm D (1)  ·  Alissa Ash, Dr. (1)  ·  Amany Saleh, MD (1)  ·  Annerose Mengel, attending physician (1)  ·  Arjan Blokland, Prof. Dr. (1)  ·  Baojun Wang, Doctor (1)  ·  Benyan Luo, Doctor (1)  ·  Bin Zhang, M.D. Ph.D. (1)  ·  Breno S Diniz, MD, PhD (1)  ·  Byoung Seok Ye, MD, PhD (1)

Results publications

PMID 20146803, PMID 20204386, PMID 21525519, PMID 23040716, PMID 24257429, PMID 25093483, PMID 26420269, PMID 27871675, PMID 28095900, PMID 28363933, PMID 28673322, PMID 28950419, PMID 29016744, PMID 29371333, PMID 29446769, PMID 29497187, PMID 29559423, PMID 29573529, PMID 30261917, PMID 30450044, PMID 30738426, PMID 30934894, PMID 30941094, PMID 30944040, PMID 30947755, PMID 31236801, PMID 31248555, PMID 31535829, PMID 31910895, PMID 32115470, PMID 32144994, PMID 32178931, PMID 32317958, PMID 32352644, PMID 32559474, PMID 32761337, PMID 32854852, PMID 33030307, PMID 33055122, PMID 33067279, PMID 33187543, PMID 33282811, PMID 33836262, PMID 33883015, PMID 33894597, PMID 33933117, PMID 34559230, PMID 34748951, PMID 34813630, PMID 34856171

NIH funding

2014 (1), P30AG024978 (1), R01AG025502 (1), R01AG043398 (1), R44AG061981 (1), R44AG071388 (1)